UiPath is an enterprise software company best known for pioneering robotic process automation (RPA), the technology that lets software "robots" mimic repetitive human actions such as data entry and document processing. In recent years the company has repositioned its platform around AI agents, process orchestration, and intelligent automation, aiming to stay relevant as the broader software market shifts from rule-based bots to generative AI.
The $30 mark is a natural focal point for PATH stock for two reasons. First, it is a round psychological price target that has appeared in public market commentary about a potential rebound in the name. Second, the stock has already surged roughly 60% over the past year, climbing from an all-time low near $9.20 in 2026 toward the high teens. Traders looking for the "next leg" of an AI-software recovery tend to cluster around round numbers, and $30 represents a meaningful, if ambitious, extension of the recent uptrend.
PATH has traded in a wide range over the past year, from a 52-week low near $9.20 to a high near $19.84. The stock's long-term peak of roughly $90, reached in 2021 during the pandemic-era software boom, illustrates both how far the name has fallen and how much room a sustained recovery could theoretically have. Importantly, the rally into the late summer pushed shares above the average analyst price target, an unusual setup that signals the market is pricing in better outcomes than most sell-side analysts currently model.
UiPath's fundamentals have improved. In its most recent reported quarter, revenue grew at a double-digit rate year over year, annual recurring revenue (ARR) — the predictable, subscription-based portion of sales — continued to climb, and dollar-based net retention improved, suggesting existing customers are expanding their spending rather than churning. Management also raised its full-year revenue outlook, a sign of confidence in demand.
The company is also positioning itself squarely in the agentic AI conversation through its Maestro orchestration platform, which coordinates AI agents, robots, and people in unified workflows. If enterprise customers increasingly treat automation and AI orchestration as the same budget line, UiPath could capture a share of a fast-growing market and justify a higher valuation.
Despite the optimism, the distance to $30 is considerable. At current levels, the stock already trades at a premium to most analyst estimates of fair value. The consensus rating is a Hold, and the average 12-month price target sits below the current share price — meaning the stock has, in effect, front-run the analysts. UBS recently raised its target to $19 while keeping a Neutral rating and noting that upside from current levels "appears limited." Bank of America has maintained a Sell-equivalent stance.
Competition is another headwind. UiPath faces pressure from large cloud and AI platforms as well as specialized agentic-automation startups. Slower-than-expected conversion of pilot customers into paying deals, or a deceleration in net-new ARR, could quickly unwind the recent gains. Notable insider selling over recent quarters has also given some investors pause.
The analyst picture is unusually cautious for a stock that has rallied this hard. The average price target among polled analysts is roughly $13 to $15, with the highest published targets clustered in the $17 to $19 range. That leaves even the most bullish street estimates well short of $30. For PATH to reach that level, the analyst community would need to substantially revise its forecasts higher — a move that typically follows sustained revenue acceleration and margin expansion, not just a favorable narrative.
From a technical analysis perspective, the stock faces immediate resistance near its 52-week high around $20. A decisive close above that level would establish a higher trading range and open the door toward $25, with $30 as the next major psychological milestone. On the downside, support appears near $15, a round number that also coincides with a recent breakout zone, with deeper support in the $12 to $13 area where several analyst targets cluster. The long-term trend remains a recovery story rather than a confirmed breakout until the stock clears and holds above its prior highs.
UiPath trades at a premium to its own history on several measures after the rally, despite generating solid gross margins near 83% and improving free cash flow. The challenge is that revenue growth has moderated from the hyper-growth days of 2021 into the low double digits. To support a $30 share price, the market would likely need to believe that AI-driven automation reaccelerates growth well beyond current guidance — a plausible but unproven scenario.
For traders who prefer a data-driven approach to monitoring names like UiPath, Tickeron's AI Daily Buy/Sell Signals offer an AI-powered tool that continuously scans thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. These signals are designed to help traders uncover new opportunities, monitor existing positions, and identify shifting market trends more efficiently than manual screening alone. Exploring these daily signals can provide an additional layer of context when evaluating whether a move toward a target such as $30 is gaining or losing momentum.
A move to $30 for PATH stock is possible but should not be mistaken for a near-term certainty. The strongest supporting factors are improving fundamentals, rising customer retention, and a credible position in the AI-automation market. The primary obstacles are a valuation that already exceeds consensus expectations, a cautious sell-side community, and intense competition. Reaching $30 would likely require several quarters of accelerating revenue growth, stronger net-new ARR, and a wave of upward analyst revisions. Investors monitoring the name should watch the $20 resistance level as the first meaningful hurdle, followed by any changes in guidance and analyst targets.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, PATH has been closely correlated with COIN. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PATH jumps, then COIN could also see price increases.
| Ticker / NAME | Correlation To PATH | 1D Price Change % | ||
|---|---|---|---|---|
| PATH | 100% | -0.87% | ||
| COIN - PATH | 67% Closely correlated | +1.73% | ||
| CRM - PATH | 62% Loosely correlated | +1.94% | ||
| PD - PATH | 60% Loosely correlated | +2.47% | ||
| RIOT - PATH | 60% Loosely correlated | +2.48% | ||
| CLSK - PATH | 60% Loosely correlated | +6.80% | ||
More | ||||
| Ticker / NAME | Correlation To PATH | 1D Price Change % |
|---|---|---|
| PATH | 100% | -0.87% |
| Computer Communications industry (165 stocks) | 9% Poorly correlated | -0.21% |